Kelyniam Global Inc
Kelyniam Global, Inc., a medical device manufacturing company, engages in the production of custom prosthetics cranial implants utilizing computer aided design, and computer aided manufacturing of advanced medical grade polymers in the United States. The company is also involved in the development, manufacture, and distribution of custom cranial implant for patients requiring the reconstruction o… Read more
Market Cap & Net Worth: Kelyniam Global Inc (KLYG)
Kelyniam Global Inc (PINK:KLYG) has a market capitalization of $9.10 Million ($9.10 Million) as of March 19, 2026. Listed on the PINK stock exchange, this USA-based company holds position #47431 globally and #14668 in its home market, demonstrating a 0.00% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Kelyniam Global Inc's stock price $0.18 by its total outstanding shares 50543430 (50.54 Million).
Kelyniam Global Inc Market Cap History: 2015 to 2025
Kelyniam Global Inc's market capitalization history from 2015 to 2025. Data shows growth from $2.02 Million to $9.10 Million (15.77% CAGR).
Kelyniam Global Inc Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Kelyniam Global Inc's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
2.43x
Kelyniam Global Inc's market cap is 2.43 times its annual revenue
0.67x
Higher than industry averageLatest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2015 | $2.02 Million | $1.52 Million | -$39.96K | 1.33x | N/A |
| 2016 | $1.52 Million | $1.53 Million | -$13.51K | 0.99x | N/A |
| 2017 | $581.25K | $1.85 Million | -$72.54K | 0.31x | N/A |
| 2018 | $3.69 Million | $2.12 Million | -$15.30K | 1.74x | N/A |
| 2019 | $5.31 Million | $2.18 Million | -$357.95K | 2.43x | N/A |
| 2020 | $9.10 Million | $2.51 Million | $141.07K | 3.62x | 64.49x |
| 2021 | $5.05 Million | $2.66 Million | $201.74K | 1.90x | 25.05x |
| 2022 | $4.04 Million | $3.02 Million | -$97.56K | 1.34x | N/A |
| 2023 | $3.03 Million | $2.67 Million | -$218.47K | 1.13x | N/A |
| 2024 | $8.09 Million | $3.33 Million | -$920.21K | 2.43x | N/A |
Competitor Companies of KLYG by Market Capitalization
Companies near Kelyniam Global Inc in the global market cap rankings as of March 19, 2026.
Key companies related to Kelyniam Global Inc by market ranking:
- Abbott Laboratories (NYSE:ABT): Ranked #78 globally with a market cap of $191.37 Billion USD.
- Stryker Corporation (NYSE:SYK): Ranked #154 globally with a market cap of $121.03 Billion USD.
- Medtronic PLC (NYSE:MDT): Ranked #168 globally with a market cap of $113.17 Billion USD.
- Boston Scientific Corp (NYSE:BSX): Ranked #185 globally with a market cap of $105.26 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #78 | Abbott Laboratories | NYSE:ABT | $191.37 Billion | $110.71 |
| #154 | Stryker Corporation | NYSE:SYK | $121.03 Billion | $349.11 |
| #168 | Medtronic PLC | NYSE:MDT | $113.17 Billion | $88.44 |
| #185 | Boston Scientific Corp | NYSE:BSX | $105.26 Billion | $71.20 |
Kelyniam Global Inc Historical Marketcap From 2015 to 2025
Between 2015 and today, Kelyniam Global Inc's market cap moved from $2.02 Million to $ 9.10 Million, with a yearly change of 15.77%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2025 | $9.10 Million | +12.50% |
| 2024 | $8.09 Million | +166.67% |
| 2023 | $3.03 Million | -25.00% |
| 2022 | $4.04 Million | -20.00% |
| 2021 | $5.05 Million | -44.44% |
| 2020 | $9.10 Million | +71.43% |
| 2019 | $5.31 Million | +43.84% |
| 2018 | $3.69 Million | +534.78% |
| 2017 | $581.25K | -61.67% |
| 2016 | $1.52 Million | -25.00% |
| 2015 | $2.02 Million | -- |
End of Day Market Cap According to Different Sources
On Mar 18th, 2026 the market cap of Kelyniam Global Inc was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $9.10 Million USD |
| MoneyControl | $9.10 Million USD |
| MarketWatch | $9.10 Million USD |
| marketcap.company | $9.10 Million USD |
| Reuters | $9.10 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.